To confirm the role of CDKN2A in gliomas, we detected the levels of CDKN2A expression in 61 glioma tissues by immunohistochemstry (IHC) (Figure 1A, C) and western blot (Figure 1B). The gene discussed is CDKN2A; the disease is central nervous system cancer.